{
    "title": "111_hr3560",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``21st Century Global Health \nTechnology Act''.\n\nSEC. 2. FINDINGS.\n\n    Congress makes the following findings:\n            (1) The United States has committed to the United Nations \n        Millennium Development Goals of--\n                    (A) reducing child mortality;\n                    (B) improving maternal health; and\n                    (C) combating HIV/AIDS, malaria, and other \n                diseases.\n            (2) The goals described in paragraph (1) cannot be reached \n        without health technologies and devices to diagnose infectious \n        diseases and reduce disease transmission.\n            (3) The development, advancement, and introduction of \n        affordable and appropriate technologies are essential to \n        efforts by the United States to reduce deaths among the world's \n        most vulnerable populations, particularly children and women in \n        the developing world.\n            (4) A recent report by the Institute of Medicine on the \n        commitment of the United States to global health--\n                    (A) recommends that United States institutions \n                share existing knowledge to address prevalent health \n                problems in low- and middle-income countries;\n                    (B) recommends continued support for partnerships \n                between the public and private sectors to develop and \n                deliver health products in low- and middle-income \n                countries; and\n                    (C) urges the United States Government to continue \n                its support for innovative research models to address \n                unmet health needs in poor countries.\n            (5) Investments by the United States in affordable, \n        appropriate health technologies, such as medical devices for \n        maternal and child care, vaccine delivery tools, safe injection \n        devices, diagnostic tests for infectious diseases, and \n        innovative disease prevention strategies--\n                    (A) reduce the risk of disease transmission; and\n                    (B) accelerate access to life-saving global health \n                interventions for the world's poor.\n            (6) Through a cooperative agreement, known as the \n        Technologies for Health program (referred to in this section as \n        ``HealthTech''), USAID supports the development of technologies \n        that--\n                    (A) maximize the limited resources available for \n                global health; and\n                    (B) ensure that products and medicines developed \n                for use in low-resource settings reach the people that \n                need such products and medicines.\n            (7) The HealthTech cooperative agreement--\n                    (A) facilitates public-private collaboration in the \n                development of global health technologies;\n                    (B) leverages public sector support for early stage \n                research and development of health technologies to \n                encourage private sector investment in late-stage \n                technology development and product introduction in \n                developing countries;\n                    (C) benefits the United States economy by investing \n                in the growing United States global health technology \n                sector, which--\n                            (i) provides skilled jobs for American \n                        workers; and\n                            (ii) enhances United States competitiveness \n                        in the increasingly technological and \n                        knowledge-based global economy; and\n                    (D) enhances United States national security by--\n                            (i) reducing the risk of pandemic disease; \n                        and\n                            (ii) contributing to economic development \n                        and stability in developing countries.\n\nSEC. 3. PURPOSE.\n\n    The purpose of this Act is to authorize a health technology \ndevelopment program that supports coordinated, long-term research and \ndevelopment of appropriate global health technologies--\n            (1) to improve global health;\n            (2) to reduce maternal and child mortality rates; and\n            (3) to reverse the incidence of HIV/AIDS, malaria, and \n        other diseases.\n\nSEC. 4. ESTABLISHMENT OF THE HEALTH TECHNOLOGY PROGRAM.\n\n    Section 107 the Foreign Assistance Act of 1961 (22 U.S.C. 2151e) is \namended by adding at the end the following:\n    ``(c) Health Technology Program.--(1) There is established in the \nUnited States Agency for International Development (referred to in this \nsection as `USAID') the Health Technology Program, which shall--\n            ``(A) coordinate and lead research and development efforts;\n            ``(B) be funded by USAID on a competitive basis; and\n            ``(C) serve as a national laboratory and technology \n        development program for global health.\n    ``(2) The Health Technology Program shall develop, advance, and \nintroduce affordable, available, and appropriate technologies \nspecifically designed--\n            ``(A) to improve the health and nutrition of developing \n        country populations;\n            ``(B) to reduce maternal and child mortality; and\n            ``(C) to improve the diagnosis, prevention and reduction of \n        disease, especially HIV/AIDS, malaria, tuberculosis, and other \n        major diseases.\n    ``(3) The Health Technology Program shall be located at an \ninstitution with a successful record of--\n            ``(A) advancing the technologies described in paragraph \n        (2); and\n            ``(B) integrating practical field experience into the \n        research and development process in order to introduce the most \n        appropriate technologies.\n    ``(4) The Administrator of USAID, in collaboration with the Health \nTechnology Program, shall submit an annual report to Congress and all \nrelevant Federal agencies that describes--\n            ``(A) the relevant activities of the Health Technology \n        Program that are in the incubation phase;\n            ``(B) the progress made on such activities and on other \n        projects carried out through the Health Technology Program; and\n            ``(C) the outlook for future health technology efforts \n        evaluated by the Health Technology Program to have significant \n        growth potential.\n    ``(5) There are authorized to be appropriated $5,000,000 for each \nof the fiscal years 2010 through 2014 to carry out the Health \nTechnology Program under this subsection.''."
}